Back to results

CompletedPhase 4

Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression

NCT00531947

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Dr. Nelson Handal

Dothan, Alabama, United States

+19 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2007-07
Enrollment: 308 participants
Sponsor: Somerset Pharmaceuticals
Purpose: treatment

Locations (20)

Dr. Nelson HandalDothan, Alabama, United States
Dr. Mohammed BariNational City, California, United States
Dr. Michael McManusSan Diego, California, United States
Dr. Elias SarkisGainesville, Florida, United States
Dr. Scott SegalNorth Miami, Florida, United States
Dr. Mary StedmanTampa, Florida, United States
Dr. Irving KolinWinter Park, Florida, United States
Dr. Rory MurphyOverland Park, Kansas, United States
Dr. Andrew SedilooOwensboro, Kentucky, United States
Dr. Bruce WaslickSpringfield, Massachusetts, United States
Dr. Christopher KratochvilOmaha, Nebraska, United States
Dr. Ann ChildressLas Vegas, Nevada, United States
Dr. Melissa DelBelloCincinnati, Ohio, United States
Dr. Leland DennisOklahoma City, Oklahoma, United States
Dr. David BrownAustin, Texas, United States
Dr. Alain KaticBellaire, Texas, United States
Dr. Graham EmslieDallas, Texas, United States
Dr. Mary ShemoCharlottesville, Virginia, United States
Dr. John GilliamRichmond, Virginia, United States
Dr. Arifulla KhanBellevue, Washington, United States

Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression — TrialFind